This is eloquently demonstrated in the murine pancreatic BMFA3 tumor model, where treatment with an anti-TGF-βR2 antibody significantly slowed the growth of Tgfbr2-mutant tumors but increased the growth of Tgfbrwt tumors (56). This evidence concerns the gene TGFBR2 and neoplasm.